An evaluation of the chronic lymphocytic leukemia (CLL) international prognostic index as a prognostic tool in patients with relapsed/refractory CLL in idelalisib phase 3 randomized studies Meeting Abstract

  

Authors:	Soumerai, J. D.; Barrientos, J. C.; Hallek, M.; Kipps, T. J.; Jones, J. A.; Stilgenbauer, S.; Xing, G.; Yao, N. S.; Ysebaert, L.; Zelenetz, A. D.
Abstract Title:	An evaluation of the chronic lymphocytic leukemia (CLL) international prognostic index as a prognostic tool in patients with relapsed/refractory CLL in idelalisib phase 3 randomized studies
Meeting Title:	52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	34
Issue:	15 Suppl.
Meeting Dates:	2016 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2016-05-20
Start Page:	398s
Language:	English
ACCESSION:	WOS:000404711505027
DOI:	10.1200/JCO.2016.34.15_suppl.7513
PROVIDER:	wos
Notes:	Meeting Abstract: 7513 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/155108